Case File
efta-02615625DOJ Data Set 11OtherEFTA02615625
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02615625
Pages
6
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
To:
Cc:
Subject:
Hi Harry,
Boris Nikolic
Tuesday, November 6, 2018 4:19 PM
[email protected]
RE: Re:
I am in Seattle this week and last night I had chance to meet with few people from BMGF.
I was told that BMGF will not fund (directly) female condom projects going forward.
There were some projects several years back but these are now terminated.
As I was suspecting, for the most part it is an issue of procurement so this is now in hands of partners such as PATH, PSI
Sorry that I can't be of more help
Best
Boris
From:
Sent: Saturday, November 3, 2018 11:32 AM
To: Boris Nikolic
Cc: jeevacation@gmal .com
Subject: Re:
Hi Boris
EFTA_R1_01815393
EFTA02615625
Currently The Female Health division of VERU supplies approximately 50 million Female Condoms worldwide. BMGF has
never funded the FC2 Female condom. I don't know why this is the case.
The FC2 female condom is the most demanded and utilized female condom worldwide. It is supplied throughout Africa
via UNFPA and bought directly by South Africa.
Funding by UNFPA has dramatically decreased and we are unable to supply certain countries that have requested the
female condom.
For example, the following countries have requested the FC2 female condom but we are unable to supply:
Uganda : 3 million units
Ghana: 1 million units
Botswana: 1 million units
Tunesia: 1 million units
Sierra Leone: 500,000 units
Bolivia: 500,000 units
Tanzania: 1 million units
Haiti: 500,000 units
Ethiopia: 1 million units
Congo DR: 2 million units
Boris, can you introduce me to the right person at BMGF to see if we can get grants to provide FC2 female condoms to
all women who request them in Africa.
Also attached is more information regarding the FC2 female condom.
Would like to continue the conversation.
Sincerely,
Harry
2
EFTA_R1_01815394
EFTA02615626
Original Messa e
From: Boris Nikolic
To: harryfisch
Cc: jeevacation <[email protected] <mailto:[email protected]»
Sent: Sat, Nov 3, 2018 1:27 pm
Subject: RE: Re:
Thank you Harry!
Again — great meeting you. I am still laughing re inherited STD.
Finally I had chance to read your slide deck. VERU is indeed very interesting company — congrats!
You have an interesting mix of Urology specialty drugs (which I see as a low risk) and Prostate cancer drugs.
Unfortunately my fund (https://www.biomaticscapital.com/) is only focused (and restricted to investing) on private
companies.
Mid-end of the next year I am going to fundraise a crossover fund which would allow me to invest in both private and
publicly listed companies; nevertheless, I am now unable to invest in companies such as VERU — despite how interesting
they might be.
I looked at a female condom. I think that PATH supported a number of related projects.
https://www.path.oreartides/seven-secrets-of-the-female-condom/ <https://www.path.orearticles/seven-secrets-of-
the-female-condomh
As you might know BMGF is the main donor to PATH — this is why I mentioned it.
Also BMGF founded several smaller grants (GCE) re female condoms https://www.gatesfoundation.org/Media-
Center/Press-Releases/2014/06/GCE-Round-12 <https://www.gatesfoundation.org/Media-Center/Press-
Releases/2014/06/GCE-Round-12>
In addition, there were grants to Imperial College in London, HealthRock etc.
All of these are relatively old grants that ended. My guess is that all female condom more mature projects transitioned
to PATH.
3
EFTA_R1_01815395
EFTA02615627
Also I see that PSI has been funding marketing and delivery https://www.psi.org/2018/03/fresh-start-female-condom-
marketing/ <https://www.psi.org/2018/03/fresh-start-female-condom-marketingh
Please let me know if there is anything else I can be of help to you.
Hope to see you soon in NYC
Best
Boris
From: [email protected]
Sent: Thursday, November 1, 2018 5:34 PM
To: Boris Nikolic
[email protected] <mailto:[email protected]>
Subject: Re:
Jeffrey thanks for introducing me to Boris.
Boris, great meeting you as well.
Attached is the most recent deck for VERU (NASDAQ: VERU), www.verupharma.com <http://www.verupharma.com> .
In addition please look at www.femalecondom.com <http://www.femalecondom.com> . We merged with The Female
Health Company which sells the FC2 Female Condom to the public sector in Africa and Brazil via UNFPA and USAID. We
just recently introduced this condom into the US market mainly via telemedicine.
Would love to meet and discuss further.
4
EFTA_R1_01815396
EFTA02615628
Sincerely,
Harry
Harry Fisch MD
Original Messag
From: Boris Nikolic
To: 1 <[email protected] <mailto:[email protected]»; Harry Fisch
senr: i nu, NOV 1, LU18 4:
Subject: RE:
Thank you J!
Great meeting you Harry!
looking forward to seeing you again.
Please send me something re your company.
Best
Boris
From: J <[email protected] <mailto:[email protected]»
Sent: Thursday, November 1, 2018 3:15 PM
To: Boris Nikolic
Subject:
harry boris , boris harry
Harry Fisch
5
EFTA_R1_01815397
EFTA02615629
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
6
EFTA_R1_01815398
EFTA02615630
Technical Artifacts (17)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Phone
2615625Phone
2615626Phone
2615627Phone
2615628Phone
2615629Phone
2615630URL
http://www.femalecondom.comURL
http://www.verupharma.comURL
https://www.biomaticscapital.comURL
https://www.gatesfoundation.org/MediaURL
https://www.gatesfoundation.org/Media-Center/PressURL
https://www.path.orearticles/seven-secrets-ofURL
https://www.path.oreartides/seven-secrets-of-the-female-condomURL
https://www.psi.org/2018/03/fresh-start-female-condomURL
https://www.psi.org/2018/03/fresh-start-female-condom-marketinghForum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.